Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12 USD | +0.17% |
|
-2.04% | +38.57% |
24/05 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
24/05 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.57% | 246.31Cr | |
+18.52% | 3,31300Cr | |
+18.50% | 9.35TCr | |
+16.95% | 8.73TCr | |
+48.86% | 5.69TCr | |
-20.85% | 4.94TCr | |
+35.19% | 4.76TCr | |
+87.65% | 4.36TCr | |
-33.78% | 4.1TCr | |
-3.71% | 2.71TCr |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating